New Multidrug Resistance Reversal Agents

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|4|1|31-43

ISSN： 1389-4501

Source： Current Drug Targets, Vol.4, Iss.1, 2003-01, pp. : 31-43

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Two-complementary Method Assay for Screening New Reversal Agents of Cancer Cell Multidrug Resistance

By Simon Pierre-Noël   Chaboud Annie   Darbour Nicole   Di Pietro Attilio   Dumontet Charles   Raynaud Jean   Barron Denis  

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 41, Iss. 1, 2003-02 ,pp. : 72-77

Informa Healthcare

Access to resources Recommend Favorite

Verapamil metabolites: potential P-glycoprotein-mediated multidrug resistance reversal agents

By Woodland Cindy   Koren Gideon   Wainer Irving W   Batist Gerry   Ito Shinya  

Canadian Journal of Physiology and Pharmacology, Vol. 81, Iss. 8, 2003-08 ,pp. : 800-805

NRC Research Press

Access to resources Recommend Favorite

Approaches to multidrug resistance reversal

By Robert J.  

Expert Opinion on Investigational Drugs, Vol. 7, Iss. 6, 1998-06 ,pp. : 929-939

Informa Healthcare

Access to resources Recommend Favorite

Dihidro-&bgr;-Agarofuran Sesquiterpenes: A New Class of Reversal Agents of the Multidrug Resistance Phenotype Mediated by P-Glycoprotein in the Protozoan Parasite Leishmania

By  

Current Pharmaceutical Design, Vol. 11, Iss. 24, 2005-09 ,pp. : 3125-3139

Bentham Science Publishers

Access to resources Recommend Favorite

Reversal of P-glycoprotein associated multidrug resistance by new isoprenoid derivatives

By Hayashi1 M.   Koike2 K.   Rho14 M-C.   Kuwano3 M.   Kishiye2 T.   Komiyama1 K.  

Anti-Cancer Drug Design, Vol. 16, Iss. 4, 2001-08 ,pp. : 255-260

Cognizant Communication Corporation

Access to resources Recommend Favorite